Grants per year
Personal profile
Research Interests
In my lab we are interested in delineating the molecular mechanisms of progesterone action through its receptor, PR in the uterus. This is done in the context of normal endometrial differentiation, specifically, decidualization, as well as in uterine pathologies, such as endometrial cancer and uterine fibroids. Specifically, we are interested in studying PR function in relation to other signaling pathways and transcription factors.
Education/Academic qualification
PhD, Universite Laval, Quebec
… → 1995
Research interests
- Molecular Biology
- Reproduction
- Women's Health / Women's Reproductive Health
- Cancer: Female Reproductive System (ovary, cervix, uterus)
Fingerprint Dive into the research topics where J Julie Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 14 Similar Profiles
Leiomyoma
Medicine & Life Sciences
Endometrial Neoplasms
Medicine & Life Sciences
Progesterone Receptors
Medicine & Life Sciences
Stromal Cells
Medicine & Life Sciences
Endometrium
Medicine & Life Sciences
Endometriosis
Medicine & Life Sciences
Progesterone
Medicine & Life Sciences
Insulin-Like Growth Factor Binding Protein 1
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2003 2024
PCOS and androgen-related disease modeling and drug testing in Multi-organ Integrated Microfluidic Reproductive Platform
Woodruff, T. K., Kim, J. J. & Urbanek, M.
National Institute of Environmental Health Sciences
9/15/19 → 8/31/22
Project: Research project
Microfluidics
Testing
Screening
Hormones
Biosensors
Understanding Progesterone Receptor action in Obesity for Endometrial Cancer Prevention
7/1/19 → 6/30/24
Project: Research project
Progestins
Breast Neoplasms
Progesterone
Progesterone Receptors
Breast
Progesterone Signaling and Blockade in Human Breast Tumorigenesis and Prevention
Clare, S. E., Khan, S. A., Kim, J. J. & Scholtens, D. M.
8/3/15 → 7/31/20
Project: Research project
Progesterone
Carcinogenesis
Breast
Progestins
Breast Neoplasms
Project 3 for Uterine Leiomyoma Research Center Program
National Institute of Child Health and Human Development
8/1/15 → 7/31/20
Project: Research project
Leiomyoma
Research
Growth
Progestins
Cytoplasmic and Nuclear Receptors
Research Output 1994 2018
Application of ex-vivo spheroid model system for the analysis of senescence and senolytic phenotypes in uterine leiomyoma
Xie, J., Xu, X., Yin, P., Li, Y., Guo, H., Kujawa, S., Chakravarti, D., Bulun, S. E., Kim, J. J. & Wei, J-J., Dec 1 2018, In : Laboratory Investigation. 98, 12, p. 1575-1587 13 p.Research output: Contribution to journal › Article
Leiomyoma
Systems Analysis
Phenotype
Genes
Myometrium
2
Citations
(Scopus)
Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations
Xie, J., Ubango, J., Ban, Y., Chakravarti, D., Kim, J. J. & Wei, J-J., Oct 1 2018, In : Genes Chromosomes and Cancer. 57, 10, p. 485-494 10 p.Research output: Contribution to journal › Article
Leiomyoma
Biomarkers
Mutation
Genes
Up-Regulation
Establishment of breast tumor spheroids: An emerging research tool
Akasha, A. M. & Kim, J. J., Mar 1 2018, In : Molecular reproduction and development. 85, 3, 1 p.Research output: Contribution to journal › Comment/debate
Open Access
Breast Neoplasms
Research
4
Citations
(Scopus)
Fumarate Hydratase Mutations and Alterations in Leiomyoma with Bizarre Nuclei
Zhang, Q., Poropatich, K., Ubago, J., Xie, J., Xu, X., Frizzell, N., Kim, J. J., Kong, B. & Wei, J-J., Sep 1 2018, In : International Journal of Gynecological Pathology. 37, 5, p. 421-430 10 p.Research output: Contribution to journal › Article
Fumarate Hydratase
Leiomyoma
Mutation
Smooth Muscle Tumor
Myometrium
2
Citations
(Scopus)
Hormonal strategies in gynecologic cancer: Bridging biology and therapy
Nieves-Neira, W., Kim, J. J. & Matei, D. E., Aug 1 2018, In : Gynecologic Oncology. 150, 2, p. 207-210 4 p.Research output: Contribution to journal › Editorial
Neoplasms
Therapeutics